Parallel Neurodegenerative Phenotypes in Sporadic Parkinsons Disease Fibroblasts and Midbrain Dopamine Neurons
Mandi J. Corenblum, A. C. E. McRobbie‐Johnson, E. Carruth, Kelsey Bernard, Moulun LuoiD, LJ Mandarino, Steven L. PetersoniD, Maria Assumpció Sans-FuentesiD, Dean D. BillheimeriD, Timothy David Maley, Erika D. EggersiD, Lalitha MadhavaniD
Abstract
Understanding the mechanisms causing Parkinsons disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they also differed in their nature and scale. Furthermore, statistical analysis revealed novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 13
- FWCI
- 2.21
- Field percentile
- top 12%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduced synaptic activity and dysregulated extracellular matrix pathways are common phenotypes in midbrain neurons derived from sporadic and mutation-associated Parkinson's disease patients
Shani Stern, Shong Lau, … Fred H. Gage·bioRxiv·Dec 31, 2021
- Age-related pathological impairments in induced neurons derived from patients with idiopathic Parkinson's disease
Janelle Drouin‐Ouellet, Karolina Pircs, … Malin Parmar·bioRxiv·Apr 23, 2021
- Synaptic dysfunction and dysregulation of extracellular matrix-related genes in dopaminergic neurons derived from Parkinson's disease sporadic patients and with GBA1 mutations
Idan Rosh, Utkarsh Tripathi, … Shani Stern·bioRxiv·Apr 10, 2023
- Diverging Parkinson's Disease Pathology between GBAN370S ,LRRK2G2019S and engineered SNCAA53T iPSC-derived Dopaminergic Neurons
Ali Fathi, Kiranmayee Bakshy, … Jing Liu·bioRxiv·Jan 6, 2023
- Bioenergetic and Protein Processing Imbalances Synergize in iPSC-Dopamine neurons from Individuals with Idiopathic Parkinsons Disease
Kelsey Bernard, Mandi J. Corenblum, … Lalitha Madhavan·Neurobiology of DiseasePeer-reviewed·Dec 12, 2025
- Recapitulating Parkinson's pathology in human iPSC dopaminergic neurons reveals new mechanistic insights into Lewy body formation and heterogeneity.
Anne‐Laure Mahul‐Mellier, Lukas van den Heuvel, … Hilal Ahmed Lashuel·bioRxiv·Oct 26, 2025